Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial-Reference-Cited by-同舟云学术

Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial

Published:2018-01 Issue:1 Volume:3 Page:47-56
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Hamaguchi Tetsuya,Shimada Yasuhiro,Mizusawa Junki,Kinugasa Yusuke,Kanemitsu Yukihide,Ohue Masayuki,Fujii Shoichi,Takiguchi Nobuhiro,Yatsuoka Toshimasa,Takii Yasumasa,Ojima Hitoshi,Masuko Hiroyuki,Kubo Yoshiro,Mishima Hideyuki,Yamaguchi Takashi,Bando Hiroyuki,Sato Toshihiko,Kato Takeshi,Nakamura Kenichi,Fukuda Haruhiko,Moriya Yoshihiro

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project;Matsuda;Jpn J Clin Oncol,2014

2. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer;Haller;J Clin Oncol,2011

3. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses;Yothers;J Clin Oncol,2011

4. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;Andre;J Clin Oncol,2009

5. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer;Sakamoto;Br J Cancer,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accrual and statistical power failure in published adjuvant phase III oncology trials: a comprehensive analysis from 2013 to 2023;ESMO Open;2024-07

2. Localized colorectal cancer database integrating 4 randomized controlled trials; (JCOG2310A);European Journal of Surgical Oncology;2024-06

3. DYRK2 promotes chemosensitivity via p53‐mediated apoptosis after DNA damage in colorectal cancer;Cancer Science;2023-09-30

4. Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials;Japanese Journal of Clinical Oncology;2023-08-19

5. Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer;Annals of Surgery;2023-08-08